Drugs / Na-3-OHB
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04703361 | Feb → Sep 2021 | systolic heart failure | University of Aarhus | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Na-3-OHB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04703361 ↗ |
| Known as | 3-hydroxybutyrate | “The ketone body 3-hydroxybutyrate (3-OHB) increases cardiac output” PMID 37301762 ↗ Jun 2023 |
| Known as | 3-OHB | “The ketone body 3-hydroxybutyrate (3-OHB) increases cardiac output” PMID 37301762 ↗ Jun 2023 |
| Action | Activate | “3-OHB activates the hydroxycarboxylic acid receptor 2 (HCA2)” PMID 37301762 ↗ Jun 2023 |